#R&D Services and Products
- Gene therapy
- Therapeutic proteins
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.Discover >
Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
#R&D Services and Products
Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing.
Cosmetic and therapeutic molecules from plant biomass.
The association of two complementary teams from the MPI/LAMBE laboratories at the University of Évry and the molecular biophysics laboratory at Orléans led to the development of two patented polymer families for nucleic acid transfection.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Two families of synthetic agents have been developed. The first is derived from polyethylenimine and the second is formed by amphiphilic triblock copolymers for in vitro and in vivo applications. These compounds offer better efficacy and lower toxicity than market references.
CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
New formulas are currently under development at the MPI lab (UEVE).
Common research with biomanufacturers showed the high performances (high efficacy, low toxicity) of these vectors for biomanufacturing in large volumes (higher than 50L) (GMP quality available).
We are looking for partnerships and co-development opportunities with biomanufacturers, companies offering high throughput cell screening and biotechnology laboratories developing DNA or RNA vaccines. Companies interested in new molecules of therapeutic or cosmetic interest from plant biomass.
Annual turnover: Greater than €100,000
1 exclusive license from the university of Évry
2 staff members
high performance synthetic vectors.
Complementary teams in chemistry and biochemistry.
ability to develop high efficacy transfecting agents for specific applications (stem cells and cell suspension cultures).
new formulations for RNA transfer.
In same field
Quibiotic develops three molecular synthesis platforms aimed at innovatively modifying β-lactam rings for new anti-infectives.Discover
ADLIN Science accompanies researchers in the management, analysis and valorization of multiomic dataDiscover
Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.Discover
Yubsis provides Biological Science Information Solutions. Our platform is designed for research organizations (Pharma, Biotech, academic lab) willing to improve real-time teamwork, optimize performance and accelerate innovation.Discover
XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.Discover
Artificial intelligence to optimize and accelerate the development of gene therapiesDiscover
R & D services in the field of transient expression of recombinant proteins in plants.Discover
PhinC Development brings its expertise to small and mid-sized biotechs and pharmaceutical companies looking to advance their early-stage drug research.Discover
New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.Discover
Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.Discover
Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.Discover